Comment
-
-
-
-
-
Comment |
Melphalan pharmacokinetics and transplant related toxicity during autologous stem cell transplantation
- Ugur Sahin
- , Ender Soydan
- , Ayla Gokmen
- , Muhit Ozcan
- & Onder Arslan
-
-
-
Comment |
Cost-effectiveness of lenalidomide
- Antonio Olry de Labry Lima
- , Antonio Matas Hoces
- , Vicente Gimeno Ballester
- , Esmeralda Ríos Sánchez
- & Emilio Jesús Alegre del Rey
-
-
-
Comment |
Does a durian smell like a rose? The dangers of jargon
- Robert Peter Gale
- & Hillard M. Lazarus
-
-
-
Comment |
Another reason to encourage psychosocial risk assessment in hematopoietic cell transplantation
- Lori Muffly
- & Andrew Artz
-
Comment |
The big freeze may be over: a contracting universe for cryopreservation?
- Robert Peter Gale
- & Guillermo J. Ruiz-Argüelles
-
Comment |
Detection of secondary malignancy following high-dose chemotherapy in germ cell tumors: prospects and limitations
- Moussab Damlaj
- & Shahrukh K. Hashmi
-
Comment |
Association analysis between SUFU polymorphism rs17114808 and acute graft versus host disease after hematopoietic stem cell transplantation
- Marie C. Katz
- , Sebastian Michaelis
- , Darina M. Siegmund
- , Renate Koch
- , Wolfgang Bethge
- , Rupert Handgretinger
- & Markus Mezger
-
Comment |
Recommendations for reporting post-transplant relapse in AML
- A Rashidi
- , M A Linden
- , M-E Percival
- , B M Sandmaier
- , S Devine
- & D J Weisdorf
-
